BRI3BP anticorps (C-Term)
Aperçu rapide pour BRI3BP anticorps (C-Term) (ABIN635825)
Antigène
Voir toutes BRI3BP AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- BRI3 BP antibody was raised against the C terminal of BRI3 P
-
Purification
- Affinity purified
-
Immunogène
- BRI3 BP antibody was raised using the C terminal of BRI3 P corresponding to a region with amino acids GFYWRSSPSGPSNPSNPSVEEKLEHLEKQVRLLNIRLNRVLESLDRSKDK
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
BRI3BP Blocking Peptide, (ABIN938656), is also available for use as a blocking control in assays to test for specificity of this BRI3BP antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of BRI0 P antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- BRI3BP (BRI3 Binding Protein (BRI3BP))
-
Autre désignation
- BRI3BP
-
Sujet
- BRI3BP is involved in the structural dynamics of the ER and affects mitochondrial viability.It is widely expressed in animal cell types, that seems to possess a pro-apoptotic property and can potentiate drug-induced apoptosis.
-
Poids moléculaire
- 28 kDa (MW of target protein)
Antigène
-